Facebook Twitter LinkedIn Google Plus RSS

Protalex completes $2.8M private placement

By ,

Florham Park-based biopharmaceutical company Protalex announced Thursday it has completed a private placement financing in the amount of $2.82 million.

According to the announcement, the placement accredited investors in the form of 471,334 shares of common stock at $6 per share. Proceeds of the financing will be used for working capital purposes, principally to fund ongoing clinical trials and studies and related activities.


Like NJBIZ on Facebook: facebook.com/NJBIZ

Stay informed with free NJBIZ email newsletters >

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!